Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report

The European Food Safety Authority (EFSA) has proposed a conservative acceptable daily intake (ADI) of 2 mg of CBD per day as of September 2025, citing unresolved toxicological concerns and significant data gaps in human safety evidence. This move will reshape compliance, labeling, and enforcement across the EU’s fragmented CBD market. Stakeholders—from raw material suppliers and brands to retailers and compliance officers—must prepare for swift regulatory shifts in light of this new scientific opinion.
This detailed update explores the new EFSA CBD 2 mg ADI 2025 benchmark, its likely impact on Novel Food dossiers, national enforcement, product withdrawals, interim retail practices, and advertising substantiation. We also contrast the EU framework with the evolving stance of the UK Food Standards Agency (FSA), providing clarity for dual-market brands.
In September 2025, EFSA released its updated safety assessment on cannabidiol, concluding that a daily intake of more than 2 mg CBD per person could not currently be considered safe for the general population (EFSA summary, NutraIngredients coverage). The draft specifies this value as a provisional safe dose (approx. 0.0275 mg/kg for a 70 kg adult), subject to further public and industry consultation through October 2025.
Key Drivers:
While EFSA continues data collection, this 2 mg/day figure will underpin both future Novel Food authorizations and national risk management strategies.
EFSA’s updated guidance signals that pending and new Novel Food dossiers for CBD products must demonstrate:
Applicants with serving sizes or recommended daily dosages exceeding 2 mg will likely face additional scrutiny or rejection in the authorization process.
Stakeholders with dossiers already under EFSA or EC review should anticipate formal requests to align application data, labels, and risk management documentation with the new 2 mg ADI. This may require supplementary studies, active dossier management, and rapid communication with authorities.
Once EFSA finalizes its ADI recommendation, Member State authorities (Ministries of Health, food safety agencies) are expected to:
According to recent industry analysis, the pace and severity of enforcement will vary, but some states (e.g., Italy, Germany) may act within weeks of EFSA finalization, while others lag due to administrative backlogs.
Major retailers and e-commerce platforms are already preparing for rapid policy updates. This includes:
EU Novel Food compliance standards mandate that labels and marketing materials:
Updated advertising substantiation rules will further restrict promotional messages. Expect more frequent legal challenges and complaints against brands exaggerating benefits or softening EFSA warnings on-pack and online.
For the latest policy language and templates for compliant product literature, reference: EFSA FAQs and EU regulatory guidance.
The UK Food Standards Agency (FSA) continues recommending a provisional 10 mg CBD/day ADI for healthy adults as of September 2025 (FSA board minutes).
This article is for informational purposes only and does not constitute legal advice. For the latest compliance strategies and automated monitoring tools, visit CannabisRegulations.ai and stay ahead of European regulatory change.